EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujiki, H.
Right arrow Articles by Kimura, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujiki, H.
Right arrow Articles by Kimura, S.

Proceedings of the Society for Experimental Biology and Medicine, Vol 220, 225-228, Copyright © 1999 by Society for Experimental Biology and Medicine

MINIREVIEWS

Mechanistic findings of green tea as cancer preventive for humans

H Fujiki, M Suganuma, S Okabe, E Sueoka, K Suga, K Imai, K Nakachi and S Kimura
Saitama Cancer Center Research Institute, Ina, Kitaadachi-gun, Saitama 362-0806, Japan. hfuji@saitama-cc.go.jp

Based on our initial work with green tea, in which repeated topical applications of (-)-epigallocatechin gallate (EGCG), the main green tea polyphenol, inhibited tumor promotion in a two-stage carcinogenesis experiment on mouse skin (Phytother Res 1, 44-47, 1987), numerous scientists have since provided so much additional evidence of the benefits of drinking green tea that it is now an acknowledged cancer preventive in Japan, and will possibly soon be recognized as such in other countries. Our work has so far produced several important results with EGCG and green tea: a wide range of target organs in animal experiments for cancer prevention, wide bioavailability of 3H-EGCG in various organs of mice, delayed cancer onset of patients with a history of consuming over 10 cups of green tea per day, and absence of any severe adverse effects among volunteers who took 15 green tea tablets per day (2.25 g green tea extracts, 337.5 mg EGCG, and 135 mg caffeine) for 6 months. This paper introduces three new findings: 1) EGCG interacted with the phospholipid bilayer membrane resulting in confirmation of the sealing effect of EGCG; 2) EGCG inhibited TNF-alpha gene expression in the cells and TNF-alpha release from the cells; 3) high consumption of green tea was closely associated with decreased numbers of axillary lymph node metastases among premenopausal Stage I and II breast cancer patients, and with increased expression of progesterone and estrogen receptors among postmenopausal ones. These results provide new insights into our understanding of the mechanisms of action of tea polyphenols and green tea extract as a cancer preventive.


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
M. R. Sartippour, R. Pietras, D. C. Marquez-Garban, H.-W. Chen, D. Heber, S. M. Henning, G. Sartippour, L. Zhang, M. Lu, O. Weinberg, et al.
The combination of green tea and tamoxifen is effective against breast cancer
Carcinogenesis, December 1, 2006; 27(12): 2424 - 2433.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncolHome page
D. Didiano, T. Shalaby, D. Lang, and M. A. Grotzer
Telomere maintenance in childhood primitive neuroectodermal brain tumors
Neuro-oncol, January 1, 2004; 6(1): 1 - 8.
[Abstract] [PDF]

Home page
 J. Nutr.Home page
M. R. Sartippour, Z.-M. Shao, D. Heber, P. Beatty, L. Zhang, C. Liu, L. Ellis, W. Liu, V. L. Go, and M. N. Brooks
Green Tea Inhibits Vascular Endothelial Growth Factor (VEGF) Induction in Human Breast Cancer Cells
J. Nutr., August 1, 2002; 132(8): 2307 - 2311.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Society for Experimental Biology and Medicine.